Syros
Syros is a Massachusetts-based biopharmaceutical company that develops and commercializes small-molecule gene therapeutics for the treatment of cancer and genetic diseases.
Business Model:
Revenue: $23.4M
Employees: 51-200
Industries / Tags:
Detailed Syros Information
Geographic Data
Address: 35 CambridgePark Drive
City: Cambridge
State: MA
Zip: 02140
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$130M
Raised Total:$501M
Social
Metrics
2,341,902Website Global Rank
7,951Website Monthly Traffic
Twitter Followers
Description
Syros is a Massachusetts-based biopharmaceutical company that develops and commercializes small-molecule gene therapeutics for the treatment of cancer and genetic diseases.
Contact Phone:
+16177441340
Contact Email:
Syros went public on 6/30/2016 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
6/30/2016
Ticker Symbol:
SYRS
IPO Price:
$12.5/share
Amount Raised:
$50M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
